SUBSCRIBE
SUBSCRIBE

Alliances

Ablynx Seals Nanobody R&D Deal Worth $2.8 Billion With Drug Giant Sanofi
Business
Ablynx Seals Nanobody R&D Deal Worth $2.8 Billion With Drug Giant Sanofi
July 20, 2017
 · 
2 min read
Roche Slammed With Partial Holds for Two Combo Cancer Trials
Business
Roche Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to ORYZON Genomics
July 20, 2017
 · 
2 min read
Business
New Abbott Diabetes Deal Is A “Missed Opportunity” For DexCom
July 14, 2017
 · 
1 min read
BioSpace partners with BIO Business Solutions to offer cost savings to BIO members
Business
BioSpace Partners With BIO Business Solutions To Offer Cost Savings To BIO Members
July 12, 2017
 · 
1 min read
Ex-Akebia Director Re-arrested After Insider Trading Prosecutors Call Him Unhinged
Business
Bay Area’s OncoMed Tanks Some More as GlaxoSmithKline Walks Away From R&D Pact
July 11, 2017
 · 
2 min read
Sanofi Finally Closes a Deal, Pays $750 Million for This Connecticut Biotech
Business
Sanofi Finally Closes a Deal, Pays $750 Million for This Connecticut Biotech
July 11, 2017
 · 
3 min read
Celgene Cuddles Up With Another Cambridge Biotech, This Time to Tackle Autoimmune Diseases
Business
The 3 Biotechs That Could Make Celgene Even Richer
July 10, 2017
 · 
2 min read
Business
How Transformative Is This Licensing Deal For BeiGene?
July 7, 2017
 · 
1 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Business
Capricor Falls as Johnson & Johnson Bails on Stem Cell Heart Med
July 7, 2017
 · 
3 min read
Japan's Konica Minolta Takes Out SoCal Diagnostics Firm Ambry Genetics in $1 Billion Deal
Business
Japan’s Konica Minolta Takes Out SoCal Diagnostics Firm Ambry Genetics in $1 Billion Deal
July 6, 2017
 · 
3 min read
Load More
PRESS RELEASES
Press Releases
Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma
August 28, 2025
 · 
3 min read
Press Releases
Pendopharm® signs an exclusive distribution agreement with Neuraxpharm for PrBuccolam® in Canada and announces its approval by Health Canada
August 4, 2025
 · 
4 min read
Press Releases
Regenerex Pharma, Inc. Enters Into Licensing Agreement with Holista Colltech Ltd.
July 31, 2025
 · 
3 min read
Press Releases
Accelerating Impact: AstraZeneca and Revna Biosciences Expand Access to Lung Cancer Treatment in Ghana
July 30, 2025
 · 
4 min read
Press Releases
JCR Pharmaceuticals Enters License Agreement with Alexion for Proprietary JUST-AAV Capsids to be Used in the Development of Genomic Medicines
July 8, 2025
 · 
5 min read
Press Releases
Sumitomo Pharma America and Former Professional Quarterback Rodney Peete Say it’s Time to Go™ and Put Yourself First with Overactive Bladder Treatment Option GEMTESA®
June 30, 2025
 · 
8 min read
Press Releases
Mabwell Announces Novel Drug Technology License Agreement with Qilu Pharmaceutical for Albipagrastim alfa for Injection
June 27, 2025
 · 
5 min read
Press Releases
Miraomics, Pythia Biosciences and LatchBio Release a 30 Million Cell Atlas and an Agentric AI Framework for Molecular Data Curation
June 27, 2025
 · 
2 min read
Press Releases
Cyberlux Corporation Signs Strategic MoU with George Mason University to Accelerate Defense Innovation and Technology Commercialization
June 27, 2025
 · 
3 min read
Press Releases
Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
June 26, 2025
 · 
5 min read
Press Releases
Positive Preliminary Cohort B Results from the AGITG-led ASCEND Trial to be Presented at ESMO GI Evaluating Lisata’s Certepetide in Combination with Standard-of-Care Chemotherapy in Metastatic Pancreatic Cancer
June 26, 2025
 · 
10 min read
Press Releases
CMUH and Shine-On Biomedical Lead Taiwan’s Push into Global Exosome-Based Precision Medicine
June 26, 2025
 · 
3 min read
Press Releases
KalVista Pharmaceuticals Enters into Licensing Agreement with Pendopharm to Commercialize Sebetralstat for HAE in Canada
June 26, 2025
 · 
4 min read
Press Releases
Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset
June 25, 2025
 · 
7 min read
Press Releases
Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.
June 25, 2025
 · 
5 min read
Press Releases
Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences
June 25, 2025
 · 
5 min read
Press Releases
Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
June 25, 2025
 · 
5 min read
Press Releases
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis
June 25, 2025
 · 
6 min read
Press Releases
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
June 25, 2025
 · 
5 min read
Press Releases
ONCare Alliance and Exigent Research Launch Groundbreaking Outpatient Bispecifics Program, Redefining Cancer Care Access, Support and Innovation
June 25, 2025
 · 
3 min read
Load More